细胞学阴性女性短期HPV-DNA转阴后CIN3的五年风险:一项基于人群的队列研究
该基于人群的队列研究纳入意大利七个试点项目第二轮筛查的1230名女性,评估短暂高危HPV感染后清除者后续筛查轮次的高级别病变风险。与HPV阴性女性相比,短暂HPV感染者第二轮HPV阳性率(15% vs 3.7%)和CIN2+检出率(0.87% vs 0.23%)更高,CIN3发生3/1230(0.24%),未检出癌症。作者认为5年筛查间隔可提供合理保护,但不推荐更长间隔。
要点
- 短暂高危HPV感染清除后,后续轮次HPV阳性率15%、CIN2+检出率0.87%,均高于HPV阴性女性的3.7%和0.23%。
- CIN3发生3/1230(0.24%),与欧洲常规细胞学筛查的CIN3+(2.7‰)相似。
- 作者认为5年筛查间隔可提供合理保护,但不推荐更长间隔。
核心结论
- 基于HPV的宫颈癌筛查方案可为HPV阴性女性设定较长间隔;对短暂高危HPV感染女性需监测临床结局。
- CIN3检出率与欧洲常规细胞学筛查项目观察到的CIN3+(2.7‰)相似;5年间隔可提供合理保护,但不推荐更长间隔。
研究设计与样本
- 基于人群的队列研究,在基于人群的组织性宫颈癌筛查项目内进行HPV初筛。
- 纳入意大利七个试点项目并参加第二轮筛查的女性共1230名(1027名25-64岁和203名35-64岁)。
主要发现
- 重复HPV检测的总体依从性为84%。
- 与HPV阴性女性相比,短暂HPV感染女性第二轮HPV阳性比例更高(15% vs 3.7%),CIN2+病变比例更高(0.87% vs 0.23%)。
- 上述CIN2+病变多数(7/10)为CIN2;未检出癌症,CIN3发生3/1230(0.24%)。
关键数值与推荐
- 对HPV阳性女性基于细胞学分流,建议立即阴道镜或12个月后重复HPV检测。
- 在HPV感染清除后3-4年的后续轮次收集数据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the 5-year risk of high-grade lesions in women with a transient high-risk HPV infection. DESIGN: Population-based cohort study. SETTING: HPV primary testing within population-based organised cervical cancer screening programmes. POPULATION: Italian women enrolled in seven pilot projects and attending the second round. METHODS: On the basis of the cytology triage performed on HPV-positive women, immediate colposcopy or HPV repeat at 12 months was recommended. Data were collected at the subsequent round 3-4 years after HPV infection clearance. MAIN OUTCOME MEASURES: Rates of HPV infection, CIN2+ and CIN3+ detection at subsequent round after HPV clearance, and relative risks (RR) in comparison with HPV-negative women (with 95% confidence interval). RESULTS: Data on 1230 women (1027 aged 25-64 years and 203 aged 35-64 years) have been analysed. Overall compliance with repeat HPV testing was 84%. In comparison with HPV-negative women, those with a transient HPV infection had higher proportions of HPV positivity (15% versus 3.7%) and of CIN2+ lesions (0.87% versus 0.23%) in round two; most of these (7/10) were CIN2; no cancers were detected, and CIN3 occurred in 3/1230 (0.24%). CONCLUSIONS: HPV-based protocols for cervical cancer screening allow long intervals for HPV-negative women; it is important to monitor the clinical outcome in the women with transient high-risk HPV infection. CIN3 detection is similar to that observed in routine European cytology-based screening programmes (CIN3+: 2.7‰); 5-year intervals may provide reasonable protection but longer intervals are not recommended. TWEETABLE ABSTRACT: A screening interval of 5 years (but no longer) appears safe in women with transient HPV detection.
引用
- Del Mistro A, Giorgi Rossi P, Frayle H, et al. Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study. BJOG. 2019. PMID: 31356722. doi:10.1111/1471-0528.15893
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。